NCI director opts against breast cancer prevention trial in favor of biomarkers.
Savage
Liz
L
D000288:Administrative Personnel; D014408:Biomarkers, Tumor / Q000032:analysis*; D001943:Breast Neoplasms / Q000517:prevention & control*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D009316:National Institutes of Health (U.S.) / Q000458:organization & administration; D014481:United States
D014408:Biomarkers, Tumor